Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents — David S Perlin (HACKENSACK UNIVERS
An epidemic of multidrug-resistant (MDR) bacterial infections plagues US and global health care, and with few new drugs making it to market from an improving but still diminished pipeline, there is an
| Project title | Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents |
|---|---|
| Project number | 5U19AI142731-05 |
| PI name | David S Perlin |
| Institution | HACKENSACK UNIVERSITY MEDICAL CENTER |
| Funding mechanism | U19 |
| Agency | NIAID |
| Award amount | $6.52M |
| Fiscal year | 2023 |
| Project start | 2019-05-01T00:00:00 |
| Project end | 2025-04-30T00:00:00 |
| Abstract | An epidemic of multidrug-resistant (MDR) bacterial infections plagues US and global health care, and with few new drugs making it to market from an improving but still diminished pipeline, there is an |
| Key terms | <A baumanni><A baumannii><A. baumanni><A. baumannii><A.baumannii><Academia><Acceleration><Acinetobac |
$799/mo
Try GrantRadar →